Old Web
English
Sign In
Acemap
>
authorDetail
>
Martin Clodi
Martin Clodi
St John of God Health Care
Lipopolysaccharide
Medicine
Placebo
Immunology
Inflammation
4
Papers
6
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Intravenous administration of LPS activates the kynurenine pathway in healthy male human subjects: a prospective placebo-controlled cross-over trial.
2021
Journal of Neuroinflammation
Vincent Millischer
Matthias Heinzl
Anthi Faka
Michael Resl
Ada Trepci
Carmen Klammer
Margot Egger
Benjamin Dieplinger
Martin Clodi
Lilly Schwieler
Show All
Source
Cite
Save
Citations (0)
Storm of Cardiovascular Markers After LPS Administration in Human Volunteers.
2021
Journal of Cardiovascular Translational Research
Michael Resl
Matthias Wolfgang Heinzl
Carmen Klammer
Margot Egger
Roland Feldbauer
Johannes Pohlhammer
B. Dieplinger
Martin Clodi
Show All
Source
Cite
Save
Citations (0)
Subgroup analyses in randomized clinical trials: Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy.
2021
European Heart Journal - Cardiovascular Pharmacotherapy
Heinz Drexel
Stuart J. Pocock
Basil S. Lewis
Christoph H. Saely
Juan Carlos Kaski
Giuseppe M.C. Rosano
Gerda Tautermann
Kurt Huber
Joern F. Dopheide
Arthur Mader
Alexander Niessner
Gianluigi Savarese
Thomas Andersen Schmidt
Anne Grete Semb
Juan Tamargo
Sven Wassmann
Martin Clodi
Keld Kjeldsen
Stefan Agewall
Show All
Source
Cite
Save
Citations (0)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is not induced in artificial human inflammation and is not correlated with inflammatory response
2019
Infection and Immunity
Matthias Heinzl
Michael Resl
Carmen Klammer
Margot Egger
Benjamin Dieplinger
Martin Clodi
Show All
Source
Cite
Save
Citations (6)
1